ALVO OAKTREE ACQUISITION CORP II

Aðalfundur Alvotech S.A. boðaður 7. júní 2024

Aðalfundur Alvotech S.A. boðaður 7. júní 2024

Aðalfundur Alvotech S.A. verður haldinn föstudaginn 7. júní 2024, kl. 09.00 CEST á skrifstofu Arendt & Medernach S.A að 41A Avenue John F. Kennedy, L-1855 Lúxemborg.

Drög af dagskrá fundarins er að finna í meðfylgjandi viðhengi.

Fundargögn og allar frekari upplýsingar varðandi aðalfundinn er hægt að nálgast á heimasíðu félagsins .

Nánari upplýsingar veitir:

Alvotech, fjárfestatengsl

Benedikt Stefánsson, forstöðumaður

Viðhengi



EN
15/05/2024

Underlying

ALVOOAKTREE ACQUISITION CORP II

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OAKTREE ACQUISITION CORP II

 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Announces Webcast to Report Financial Results for the First H...

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT REYKJAVIK, ICELAND (August 6, 2025) – Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first half of the year ended June 30, 2025, after U.S. markets close on Wednesday, August 13, 2025.  Alvotech will also conduct a conference call to present the financial results and recent business highlights on Thursday August 14, ...

August 6, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech kynnir uppgjör fyrri helmings ársins 2025 þann 14. ágúst nk. ...

Alvotech kynnir uppgjör fyrri helmings ársins 2025 þann 14. ágúst nk. kl. 12 á hádegi REYKJAVÍK (6. ágúst 2025) Alvotech (NASDAQ: ALVO) mun senda út tilkynningu með uppgjöri fyrir fyrri helming ársins 2025 eftir lokun markaða í Bandaríkjunum, miðvikudaginn 13. ágúst nk. Fundur til kynningar á uppgjörinu verður sendur út í beinu streymi og hefst hann kl. 12 á hádegi, fimmtudaginn 14. ágúst nk. Streymi af uppgjörsfundinum, sem fer fram á ensku, verður aðgengilegt á fjárfestasíðu Alvotech, , á slóðinni . Þar verður einnig hægt að finna upptöku af fundinum eftir að honum er lokið, sem aðgengil...

August 6, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Inbjudan til Alvotech presentation av bokslutskommunikén och rapporten...

Inbjudan til Alvotech presentation av bokslutskommunikén och rapporten för första halvåret 2025 REYKJAVIK, ISLAND (6 AUGUSTI, 2025) – Alvotech (NASDAQ:ALVO SDB), ett globalt biofarmaceutiskt företag som specialiserar sig på utveckling och tillverkning av biosimilära läkemedel för patienter över hela världen, publicerar bokslutskommunikén för första halvåret som slutade den 30 juni 2025 den 13 augusti 2025 efter att de amerikanska marknaderna stängt. Resultaten presenteras i en webcast och telefonkonferens klockan 14:00 CET (8:00 AM EDT) den 14 augusti 2025. Presentationen hålls på engelsk...

August 6, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Announces Webcast to Report Financial Results for the First H...

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT REYKJAVIK, Iceland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first half of the year ended June 30, 2025, after U.S. markets close on Wednesday, August 13, 2025. Alvotech will also conduct a conference call to present the financial results and recent business highlights on Thu...

August 6, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer REYKJAVIK, Iceland, July 10, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda Jónsdóttir as Chief Financial Officer (CFO). Linda is a highly experienced international executive with a strong background in finance and corporate leadership. She has held senior roles across a range of industries, including banking, food technology, transportation, and healthcare. Linda w...

July 10, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch